Syncona
Venture CapitalUnited Kingdom+ Guernsey
Syncona is a Series A/Series B/Series C investor in United Kingdom. Focus: Biotech. Cheques up to £20M. See ticket size, sectors, portfolio and contact…
Min Ticket
—
Max Ticket
£20M
Stages
3 stages
Sectors
1 sectors
Investment Sectors
Details
- Headquarters
- London, United Kingdom
- Other Locations
- Guernsey
- Min Ticket
- Not disclosed
- Max Ticket
- £20M
- Reported Size
- £20 million commitment for Kesmalea Therapeutics
- General Email
- contact@synconaltd.com
View Portfolio
See companies Syncona has invested in